Public Company News

NWTN Inc. Announces Key Executive Appointments to Accelerate Strategic Transformation

DUBAI, UAE, July 7, 2025 /PRNewswire/ -- NWTN Inc. (Nasdaq: NWTN), a Nasdaq-listed company headquartered in the UAE, today announced two key executive appointments: Mr.Adrian Wong as Chief Financial Officer and Mr. John Xie as Chief Operating Officer. Both appointments are effective July 3, 2025....

2025-07-07 19:00 3913

Recurrent Energy Energizes 1,200 MWh Storage Facility in Arizona Ahead of Peak Summer Demand

First of three projects with APS now in operation, delivering flexible capacity to the grid KITCHENER, ON, July 7, 2025 /PRNewswire/ -- Recurrent Energy , a subsidiary of Canadian Solar Inc.  ("Canadian Solar") (NASDAQ: CSIQ), and a ...

2025-07-07 19:00 2099

EHGO and Photonetco Form Exclusive National Partnership to Expand in China's Office Equipment Market

SHANGHAI, July 7, 2025 /PRNewswire/ -- Eshallgo Inc. (Nasdaq: EHGO ), a leading provider of integrated office solutions inChina, today announced that its wholly owned subsidiary, Shanghai ESHALLGO Enterprise Development (Group) Co., Ltd....

2025-07-07 18:00 4058

ESG | HitGen Releases Its Inaugural Sustainability Report

CHENGDU, China, July 4, 2025 /PRNewswire/ -- Shanghai Stock Exchange listed company HitGen Inc. ("HitGen", SSE: 688222.SH) today announced the release of its inaugural sustainability report, aiming to present the company's philosophies and policies in environmental, social, and governance ("ESG")...

2025-07-04 19:00 5140

Ping An Good Doctor Selected for First Batch of "Open-Source LLMs+" Innovation Application Cases, Showcasing Medical AI Scenario Implementation

HONG KONG and SHANGHAI, July 4, 2025 /PRNewswire/ -- The "Global Digital Economy Conference - Cloud-Intelligence-Computing Security Forum," also known as the third "SecGo Security Forum," was successfully held today inBeijing. The event was organized by the Global Digital Economy Conference Organ...

2025-07-04 14:14 3275

Emeren Group Announces North America Management Change and Preliminary Q2 2025 Operating Results

NORWALK, Conn., July 3, 2025 /PRNewswire/ -- Emeren Group Ltd ("Emeren" or the "Company")(www.emeren.com ) (NYSE: SOL), a leading global solar project developer, owner, and operator, today announced a leadership transition within itsNorth America operations. Mr. Cameron "M...

2025-07-04 04:30 6026

Zhengye Biotechnology Holding Limited Announces Fiscal Year 2024 Financial Results

JILIN, China, July 3, 2025 /PRNewswire/ -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research, development, manufacturing, and sales of veterinary vaccines, with a focus on livestock vaccines inChina, toda...

2025-07-03 20:30 5012

Fangzhou Tops China's App Store Chart for Healthcare Apps

GUANGZHOU, China, July 3, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, earned the top spot in theJune 2025 China AppStore Healthcare TOP100 Free APP Rankings with its Fangzhou Online Pharmacy App, according to a report by ...

2025-07-03 18:43 2708

Yunji Announces Changes in Management

HANGZHOU, China, July 3, 2025 /PRNewswire/ -- Yunji Inc. ("Yunji" or the "Company") (NASDAQ: YJ), a leading membership-based social e-commerce platform, today announced that Mr.Yeqing Cui, has resigned as Senior Financial Director and finance in charge of the Company for personal reasons, effecti...

2025-07-03 18:30 3437

So-Young Regains Compliance with Nasdaq Minimum Bid Price Requirement

BEIJING, July 3, 2025 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform inChina connecting consumers with online services and offline treatments, today announced that it has received a written compliance notification f...

2025-07-03 17:00 4989

Akeso's First Bispecific ADC (Trop2/Nectin4 ADC) Enters Clinical Trials, Strengthening Leadership in 'IO+ADC' 2.0 Strategy

HONG KONG, July 3, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") has announced the successful enrollment of the first patient in its Phase Ia clinical trial for AK146D1, a bispecific Antibody-Drug Conjugate (ADC) targeting Trop2 and Nectin4. AK146D1 is Akeso's first bispec...

2025-07-03 14:46 2799

Dizal's ZEGFROVY® (sunvozertinib) Receives FDA Accelerated Approval as the Only Targeted Oral Treatment for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

* ZEGFROVY is the only approved targeted oral treatment for NSCLC with EGFR  exon20ins * Approval follows the U.S. FDA's Priority Review and is supported by the pivotal WU-KONG1 Part B study, in which ZEGFROVY demonstrated statistically significant and clinically meaningfulbenefits to patien...

2025-07-03 08:08 2966

Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001

Highlights: * Neurizon® Therapeutics and Elanco Animal Health enter into an exclusive global licensing agreement * Provides worldwide rights for Neurizon to utilise Elanco's intellectual property, providing exclusive access to an extensive package of non-clinical studies and manufacturing da...

2025-07-03 07:09 3704

Ascletis Announces First Participants with Obesity or Overweight Dosed in a U.S. 13-week Phase IIa Study of Small Molecule Oral GLP-1R Agonist ASC30

-  First participants with obesity or overweight with at least one weight-r elatedcomorbidity have been dosed in a U.S. 13-week Phase IIa study of small m oleculeoral GLP-1 receptor agonist ASC30. -  ASC30 oral once-daily tablet demonstrated up to 6.5% placebo-adjusted mean  body weight reduction f...

2025-07-03 07:00 2604

TROOPS, Inc. (Nasdaq: TROO) Announces Update on Hong Kong High Court Judgment and Explores Strategic Legal Options to Safeguard Shareholder Interests

HONG KONG, July 2, 2025 /PRNewswire/ -- TROOPS, Inc. (Nasdaq: TROO) (the "Company" or "TROOPS") today announced that the Company has received a judgement (the "Judgement") issued by the High Court of Hong Kong Special Administrative Region Court of First Instance in connection with the action no....

2025-07-03 04:30 5290

FiEE, Inc. Acquires Advanced Tech Suite Expected to Supercharge IoT-AI Content & Audience Targeting Platform

HONG KONG, July 2, 2025 /PRNewswire/ -- FiEE, Inc. (NASDAQ:MINM) ("FiEE" or the "Company"), a technology company integrating IoT, connectivity and AI to redefine brand management solutions in the digital era, is pleased to announce that onJune 30, 2025, it entered into an asset purchase agreement...

2025-07-03 04:30 4839

Boqii Holding Limited Announces Update on Substitution Listing and 1-for-160 Reverse Split

SHANGHAI, July 2, 2025 /PRNewswire/ -- As Boqii Holding Limited ("Boqii" or the "Company") (NYSE American: BQ) previously announced, the Company plans to cease the listing of the American Depositary Shares (the "ADSs") representing its Class A ordinary shares of par valueUS$0.001 each on the  NYS...

2025-07-02 22:48 5538

Lunit and Microsoft Collaborate to Advance AI-Driven Cancer Diagnosis

SEOUL, South Korea, July 2, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, today announced a collaboration with Microsoft to accelerate the delivery of AI-powered healthcare solutions. In conjunction with their recent acquisition of V...

2025-07-02 21:00 2878

SINEXCEL Contributes to Development of Grid-Forming Energy Storage Standards to Drive Industry Advancement

SHENZHEN, China, July 2, 2025 /PRNewswire/ -- SINEXCEL (300693.SZ), a global pioneer in modular energy storage, EV charging and power quality solutions, has played a key role in drafting two newlypublished technical standards for grid-forming energy storage systems, marking a major step toward th...

2025-07-02 21:00 3487

[iNtRON] Files U.S. Patent for Three Novel Endolysin-Based Drug Candidates Targeting Gram-Negative Bacteria

* Gram-negative bacterial infections are becoming an increasingly serious global health issue * U.S. patent applications filed for three novel drug candidates: PKL200, TSL2200, and EAL2200 * Continued diversification of business initiatives to address Gram-negative bacterial threats BOSTON ...

2025-07-02 20:00 2519
1 ... 129130131132133134135 ... 765

Week's Top Stories